BioCatalystWatch
SERWorkspace / SER / OverviewCompany library
Serina Therapeutics, Inc. logo

Serina Therapeutics, Inc.

Serina Therapeutics, Inc. (SER)

Website

Price
Market cap
Next catalystExpected 1H 2027SER-252 — Phase 1b single-ascending-dose study · Data readoutCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

SER-252

Dopamine receptors

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

SER-252

Dopamine receptors

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status
1M

Market Reaction / Supply Context

Market Structure

SER PR & News

PR & News

SER SEC archive